News
Latest news from CHV and our portfolio companies
Featured News
PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage company redefining cancer treatment with therapeutics administered continuously and exclusively at the tumor site, today announced that it has concluded dosing in
Insights & Impacts: The latest from CHV
Funding Will Support Clinical Studies of the VelocityTM pAVF System in Patients with Chronic Kidney
PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage oncology company redefining cancer treatment with therapeutics
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health
Innovative Leader in AI-Powered Brain Health Solutions Strengthens Board with Accomplished Remote Patient Monitoring Executive
After promising results from first-in-man studies with its novel Neural Ice™ technology, the Massachusetts-based company
AtaCor Medical Inc., a privately-held medical device company delivering the next generation of extravascular leads
Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings
Avive Solutions, Inc., the developer of the world’s most advanced connected automated external defibrillator (AED)
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health
Brixton Biosciences, a clinical-stage life sciences company developing novel therapies for chronic and acute pain,